People news

Share this article:
Oscient Pharmaceuticals has announced that Dominick Colangelo, executive vice president, corporate development & operations, will resign his current position, effective immediately. Colangelo will stay on with the company as a consultant until Jan. 31, 2009. The resultant corporate team at Oscient will consist of Steve Rauscher, CEO and president, Philippe Maitre, EVP and chief financial officer, and Mark Glickman, SVP, sales and marketing.
Neogenix Oncology has announced the appointment of Ted Sorensen as vice chairman. Sorensen is currently a counsel member as US law firm Paul, Weiss, Fifkind, Wharton & Garrison, and was formerly special counsel and adviser to President John F. Kennedy.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media